322 related articles for article (PubMed ID: 9496522)
1. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
[TBL] [Abstract][Full Text] [Related]
2. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
[TBL] [Abstract][Full Text] [Related]
3. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
[TBL] [Abstract][Full Text] [Related]
4. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
Kisli E; Baser M; Aydin M; Guler O
Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of post-ERCP acute pancreatitis with octreotide].
Baldazzi G; Conti C; Spotti EG; Arisi GP; Scevola M; Gobetti F; Agliardi CM; Galasso P; Bonomi E; Bianchi F
G Chir; 1994; 15(8-9):359-62. PubMed ID: 7803209
[TBL] [Abstract][Full Text] [Related]
7. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
[TBL] [Abstract][Full Text] [Related]
8. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
[TBL] [Abstract][Full Text] [Related]
10. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.
Mann DV; Kalu P; Foulds S; Edwards R; Glazer G
Endoscopy; 2001 May; 33(5):448-53. PubMed ID: 11396766
[TBL] [Abstract][Full Text] [Related]
12. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
[TBL] [Abstract][Full Text] [Related]
13. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
[TBL] [Abstract][Full Text] [Related]
14. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis.
Testoni PA; Bagnolo F; Caporuscio S; Lella F
Am J Gastroenterol; 1999 May; 94(5):1235-41. PubMed ID: 10235200
[TBL] [Abstract][Full Text] [Related]
15. [Octreotide in the prevention of hyperamylasemia following ERCP (a controlled multicenter study)].
Döbrönte Z; Juhász L; Tulassay Z
Orv Hetil; 1996 Oct; 137(42):2309-12. PubMed ID: 8992429
[TBL] [Abstract][Full Text] [Related]
16. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
[TBL] [Abstract][Full Text] [Related]
18. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
[TBL] [Abstract][Full Text] [Related]
19. Preventing post-ERCP pancreatitis: where are we?
Testoni PA
JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy.
Testoni PA; Lella F; Bagnolo F; Buizza M; Colombo E
Ital J Gastroenterol; 1994 Dec; 26(9):431-6. PubMed ID: 7541258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
